Qualigen Therapeutics (QLGN) Short Interest Ratio & Short Volume $0.24 -0.01 (-4.02%) (As of 07/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Qualigen Therapeutics Short Interest DataCurrent Short Interest4,160,000 sharesPrevious Short Interest571,500 sharesChange Vs. Previous Month+627.91%Dollar Volume Sold Short$1.61 millionShort Interest Ratio0.3 Days to CoverLast Record DateJuly 15, 2024Outstanding Shares12,160,000 sharesFloat Size10,170,000 sharesShort Percent of Float40.90%Today's Trading Volume893,163 sharesAverage Trading Volume36,080,152 sharesToday's Volume Vs. Average2% Short Selling Qualigen Therapeutics ? Sign up to receive the latest short interest report for Qualigen Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartQLGN Short Interest Over TimeQLGN Days to Cover Over TimeQLGN Percentage of Float Shorted Over Time Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Qualigen Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/20244,160,000 shares $1.61 million +627.9%40.9%0.3 $0.39 6/30/2024571,500 shares $98,469.45 +493.5%6.7%0.1 $0.17 6/15/202496,300 shares $19,163.70 +20.7%1.6%0.1 $0.20 5/31/202479,800 shares $21,546.00 +1.7%1.3%0.5 $0.27 5/15/202478,500 shares $24,083.80 +82.1%1.3%0.8 $0.31 4/30/202443,100 shares $12,921.38 -12.8%0.8%0.6 $0.30 Get the Latest News and Ratings for QLGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Qualigen Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/15/202449,400 shares $15,808.00 -38.2%0.9%0.8 $0.32 3/31/202479,900 shares $31,960.00 +588.8%1.7%1.3 $0.40 3/15/202411,600 shares $4,294.32 +11.5%0.3%0.2 $0.37 2/29/202410,400 shares $4,785.04 -63.5%0.2%0.2 $0.46 2/15/202428,500 shares $13,523.25 -3.1%0.6%0.7 $0.47 1/31/202429,400 shares $15,452.64 -14.5%0.6%1.1 $0.53 1/15/202434,400 shares $17,595.60 +63.8%0.8%1.3 $0.51 12/31/202321,000 shares $11,550.00 -32.7%0.5%0.9 $0.55 12/15/202331,200 shares $18,033.60 -8.0%0.7%1.6 $0.58 11/30/202333,900 shares $25,052.10 -15.9%0.7%2.5 $0.74 11/15/202340,300 shares $28,250.30 +0.8%0.9%2.7 $0.70 10/31/202340,000 shares $31,108.00 +5.5%0.9%2.7 $0.78 10/15/202337,900 shares $35,091.61 -14.5%0.9%1.9 $0.93 9/30/202344,300 shares $44,743.00 +23.1%1.0%1.7 $1.01 9/15/202336,000 shares $37,800.00 +77.3%0.8%1.4 $1.05 8/31/202320,300 shares $21,112.00 -9.8%0.5%0.8 $1.04 8/15/202322,500 shares $24,525.00 -37.0%0.5%0.9 $1.09 7/31/202335,700 shares $40,341.00 +28.4%0.8%1.2 $1.13 7/15/202327,800 shares $30,749.58 -12.3%0.6%1.1 $1.11 6/30/202331,700 shares $28,878.70 +26.3%0.7%1.1 $0.91 6/15/202325,100 shares $24,098.51 -38.6%0.6%0.7 $0.96 5/31/202340,900 shares $37,746.61 +7.4%0.9%0.2 $0.92 5/15/202338,100 shares $38,862.00 -39.9%0.9%0.2 $1.02 4/30/202363,400 shares $59,507.24 -5.4%1.5%0.4 $0.94 4/15/202367,000 shares $63,650.00 -19.2%1.8%0.4 $0.95 3/31/202382,900 shares $76,690.79 +48.8%2.2%0.2 $0.93 3/15/202355,700 shares $56,257.00 -31.0%1.5%0.2 $1.01 2/28/202380,700 shares $92,466.06 +41.6%2.1%0.3 $1.15 2/15/202357,000 shares $70,965.00 -17.2%1.5%0.2 $1.25 1/31/202368,800 shares $88,752.00 -61.2%1.8%0.3 $1.29 1/15/2023177,200 shares $237,448.00 +84.8%4.6%0.8 $1.34 12/30/202295,900 shares $123,615.10 No Change2.5%0.5 $1.29 12/15/202295,900 shares $136,178.00 +18.1%2.5%3.7 $1.42 11/30/202281,200 shares $121,597.00 -11.8%2.1%3.1 $1.50625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here 11/15/202292,100 shares $20,308.05 -90.0%N/A4.3 $0.22 10/31/2022916,300 shares $201,586.00 -2.7%N/A4.3 $0.22 10/15/2022941,700 shares $253,128.96 -15.9%N/A4 $0.27 9/30/20221,120,000 shares $299,040.00 +25.5%N/A4.7 $0.27 9/15/2022892,200 shares $291,927.84 -11.7%N/A3.6 $0.33 8/31/20221,010,000 shares $384,406.00 -1.0%N/A4.3 $0.38 8/15/20221,020,000 shares $433,500.00 -8.9%N/A4.5 $0.43 7/31/20221,120,000 shares $469,056.00 -2.6%N/A4.8 $0.42 7/15/20221,150,000 shares $535,670.00 -2.5%N/A5.1 $0.47 6/30/20221,180,000 shares $672,246.00 -9.9%N/A1 $0.57 6/15/20221,310,000 shares $793,467.00 -9.0%N/A1.2 $0.61 5/31/20221,440,000 shares $807,840.00 +2.1%N/A1.3 $0.56 5/15/20221,410,000 shares $751,530.00 +13.7%N/A1.2 $0.53 4/30/20221,240,000 shares $706,800.00 -43.9%N/A1.1 $0.57 4/15/20222,210,000 shares $1.60 million +63.7%N/A1.8 $0.73 3/31/20221,350,000 shares $891,000.00 +3.9%N/A3.9 $0.66 3/15/20221,300,000 shares $741,000.00 -3.7%N/A0.7 $0.57 2/28/20221,350,000 shares $891,000.00 +2.3%N/A0.6 $0.66 2/15/20221,320,000 shares $970,860.00 -7.0%N/A0.2 $0.74 1/31/20221,420,000 shares $1.24 million -7.8%N/A0.2 $0.87 1/15/20221,540,000 shares $1.62 million -36.1%5.8%0.2 $1.05 12/31/20212,410,000 shares $2.58 million +33.9%9.3%0.3 $1.07 12/15/20211,800,000 shares $1.74 million -68.4%6.9%0.2 $0.96 11/30/20215,700,000 shares $8.38 million +258.5%22.1%0.8 $1.47 11/15/20211,590,000 shares $1.70 million -7.0%6.2%0.3 $1.07 10/29/20211,710,000 shares $1.97 million +4.3%6.7%3.8 $1.15 10/15/20211,640,000 shares $1.92 million -0.6%6.4%3.7 $1.17 9/30/20211,650,000 shares $2.15 million -0.6%6.4%3.5 $1.30 9/15/20211,660,000 shares $2.39 million +16.9%6.5%3.3 $1.44 8/31/20211,420,000 shares $2.23 million -18.9%5.5%2.7 $1.57 8/13/20211,750,000 shares $3.12 million -1.1%6.8%5.2 $1.78 7/30/20211,770,000 shares $3.13 million +2.3%6.9%5 $1.77 7/15/20211,730,000 shares $2.92 million +4.2%6.8%3.4 $1.69 6/30/20211,660,000 shares $3.30 million +9.2%6.5%2.7 $1.99 6/15/20211,520,000 shares $3.19 million -16.0%6.0%2.3 $2.10 5/28/20211,810,000 shares $3.46 million +0.6%7.1%2.5 $1.91 5/14/20211,800,000 shares $2.75 million -6.3%7.1%2.1 $1.53 4/30/20211,920,000 shares $4.22 million +7.9%7.5%1.6 $2.20 4/15/20211,780,000 shares $3.65 million No Change6.3%1.1 $2.05 3/31/20211,780,000 shares $4.63 million -11.4%6.2%1.1 $2.60 3/15/20212,010,000 shares $6.69 million +24.8%7.6%1.2 $3.33 2/26/20211,610,000 shares $5.47 million -10.6%6.1%0.8 $3.40 2/12/20211,800,000 shares $6.98 million -9.6%6.8%1 $3.88 1/29/20211,990,000 shares $7.12 million +3.7%7.5%1.2 $3.58 1/15/20211,920,000 shares $6.62 million No Change7.3%1.5 $3.45 QLGN Short Interest - Frequently Asked Questions What is Qualigen Therapeutics' current short interest? Short interest is the volume of Qualigen Therapeutics shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 4,160,000 shares of QLGN short. 40.90% of Qualigen Therapeutics' shares are currently sold short. Learn More on Qualigen Therapeutics' current short interest. What is a good short interest percentage for Qualigen Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 40.90% of Qualigen Therapeutics' floating shares are currently sold short. Is Qualigen Therapeutics' short interest increasing or decreasing? Qualigen Therapeutics saw a increase in short interest in the month of July. As of July 15th, there was short interest totaling 4,160,000 shares, an increase of 627.9% from the previous total of 571,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Qualigen Therapeutics' float size? Qualigen Therapeutics currently has issued a total of 12,160,000 shares. Some of Qualigen Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Qualigen Therapeutics currently has a public float of 10,170,000 shares. How does Qualigen Therapeutics' short interest compare to its competitors? 40.90% of Qualigen Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Qualigen Therapeutics: Kiora Pharmaceuticals, Inc. (0.67%), Imunon, Inc. (2.99%), Cardio Diagnostics Holdings, Inc. (1.57%), RedHill Biopharma Ltd. (1.07%), PHAXIAM Therapeutics S.A. (0.01%), Alterity Therapeutics Limited (0.21%), TC Biopharm (Holdings) Plc (0.39%), GeoVax Labs, Inc. (5.29%), TransCode Therapeutics, Inc. (0.37%), Lixte Biotechnology Holdings, Inc. (0.67%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks. What does it mean to sell short Qualigen Therapeutics stock? Short selling QLGN is an investing strategy that aims to generate trading profit from Qualigen Therapeutics as its price is falling. QLGN shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Qualigen Therapeutics? A short squeeze for Qualigen Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of QLGN, which in turn drives the price of the stock up even further. How often is Qualigen Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including QLGN, twice per month. The most recent reporting period available is July, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Kiora Pharmaceuticals Short Interest Data Imunon Short Interest Data Cardio Diagnostics Short Interest Data RedHill Biopharma Short Interest Data PHAXIAM Therapeutics Short Interest Data Alterity Therapeutics Short Interest Data TC Biopharm Short Interest Data GeoVax Labs Short Interest Data TransCode Therapeutics Short Interest Data Lixte Biotechnology Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:QLGN) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qualigen Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Qualigen Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
